Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Intangible asset (IPR&D) impairment charges by Year
Intangible asset (IPR&D) impairment charges ($M) ($M)
Vertex Pharmaceuticals Intangible asset (IPR&D) impairment charges: $379M in FY2025. That is the highest of the 9 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-Q / 10-K Consolidated Statements of Operations.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Intangible asset (IPR&D) impairment charges ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 379 | – | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 0 | – | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 0 | – | Form 10-K (filed 2026-02-13) ↗ |
| FY2020 | Dec 31, 2020 | 0 | – | Form 10-K (filed 2021-02-11) ↗ |
| FY2019 | Dec 31, 2019 | 0 | -100.0% | Form 10-K (filed 2021-02-11) ↗ |
| FY2018 | Dec 31, 2018 | 29 | -88.6% | Form 10-K (filed 2021-02-11) ↗ |
| FY2017 | Dec 31, 2017 | 255 | – | Form 10-K (filed 2020-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 0 | – | Form 10-K (filed 2019-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 0 | – | Form 10-K (filed 2018-02-15) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Intangible asset (IPR&D) impairment charges ($M), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/iprd-impairment
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.